Rhythm Pharmaceuticals, Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $22.9M | $19.6M |
| SG&A Expense | $9.5M | $6.3M |
| Operating Income | $-32.4M | $-25.9M |
| Operating Margin | — | — |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | $-33.7M | $-25.9M |
| Net Margin | — | — |
| EPS (Basic) | $-2.83 | $-2.85 |
| EPS (Diluted) | $-2.83 | $-2.85 |
| Shares Outstanding (Basic) | 27.3M | 10.2M |
| Shares Outstanding (Diluted) | 27.3M | 10.2M |
| Dividends Per Share | — | — |